Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Sensitivity and Predictive Value of Frozen Section of Sentinel Lymph Node Biopsy in Post Neoadjuvant Setting
A completed study assessing the sensitivity and predictive value of frozen-section analysis of sentinel lymph node biopsies after neoadjuvan…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: AR and ER Imaging in Metastatic Breast Cancer [Phase 2]
This update reports the completion of a Phase 2 trial evaluating imaging of androgen receptor (AR) and estrogen receptor (ER) in patients wi…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Imaging of ER Density to Guide and Improve Tailored Therapy for Acquired Anti-hormonal Resistant Breast Cancer
A completed clinical study evaluating imaging of estrogen receptor density to guide tailored therapy for anti-hormonal resistant breast canc…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Knowledge and Attitudes Regarding Healthy Lifestyle and Health Behavior Change in Cancer Patients and Their Partners; A Pilot Study
A completed pilot clinical trial evaluating knowledge and attitudes toward healthy lifestyle and health behavior change among cancer patient…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study) [Phase 2]
Phase 2 SMILE trial evaluating Onapristone in combination with Fulvestrant for ER-positive, HER2-negative metastatic breast cancer after end…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Optimizing Functional Recovery of Breast Cancer Survivors [NA]
Completed clinical trial evaluating functional recovery strategies for breast cancer survivors; results posted May 3, 2024.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: High-dose Chemotherapy With Hematopoietic Stem-cell Rescue for High-risk Breast Cancer: Long-term Follow-up
Long-term follow-up results are reported for a high-dose chemotherapy regimen with hematopoietic stem-cell rescue in patients with high-risk…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: Analysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer [Phase 2]
This Clinical Trials Update reports Phase 2 results for olaparib in patients with BRCA1/2 promoter methylation and advanced breast cancer. R…
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery [Phase 2]
A Phase 2 study evaluating ASP5354 to visualize sentinel lymph nodes during surgery in breast cancer or melanoma was terminated. Results hav…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Study of Oral Vinorelbine Plus Capecitabine Versus Taxane-gemcitabine Combinations as 1st Line Chemotherapy in Metastatic Breast Cancer [Phase 2]
Phase 2 trial comparing oral vinorelbine plus capecitabine against taxane-gemcitabine combinations as first-line therapy in metastatic breas…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: A "Window Trial" on Boswellia for Breast Cancer Primary Tumors [Phase 1]
A completed Phase 1 window trial evaluating Boswellia for primary breast cancer tumors. The study was conducted under the auspices of the Me…
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy
The clinical trial NCT04927559 on health literacy in understanding radiation therapy information for patients undergoing definitive radiatio…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1 and Phase 2 trials evaluated tinengotinib (TT-00420) as a monotherapy and in combination therapy for patients with advanced solid tu…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: The Treatment of Stage I and II Carcinoma of the Breast With Mastectomy and Axillary Dissection Versus Excisional Biopsy, Axillary Dissection, and Definitive Irradiation [Phase 3]
This Phase 3 trial comparing mastectomy with axillary dissection to excisional biopsy with axillary dissection and definitive irradiation fo…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Self-applied Acupressure for Arthralgia-fatigue-sleep Disturbance in Breast Cancer [Phase 2]
Phase 2 trial evaluating self-applied acupressure for arthralgia, fatigue, and sleep disturbance in breast cancer patients has been terminat…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure [NA]
A completed trial evaluated text message nudges delivered before primary care visits to improve closing of care gaps. The study status is co…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer [Phase 1]
The Phase 1 trial evaluating safety, tolerability, and preliminary efficacy in advanced or metastatic breast cancer has been terminated. Spo…
-
CLINICAL_TRIALS trial_result · 2024-04-24Clinical Trial Update: Cancer-related Fatigue in Patients With Breast Cancer Treatment With Zhengyuan Capsules [Phase 4]
Phase 4 trial evaluating Zhengyuan capsules for cancer-related fatigue in breast cancer patients; status not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-04-23Clinical Trial Update: A Multicenter, Double-blind, Randomized, Parallel-group, Phase III Study of the Efficacy and Safety of QL1701 Plus Docetaxel Versus Herceptin® Plus Docetaxel as First Line Therapy in Patients With HER2-positive Metastatic Breast Cancer [Phase 3]
Phase III trial comparing QL1701 plus docetaxel to Herceptin plus docetaxel as first-line therapy for HER2-positive metastatic breast cancer…
-
CLINICAL_TRIALS trial_result · 2024-04-23Clinical Trial Update: Higher Dose Preoperative taMOxifen in Premenopausal bREast Cancer Patients [Phase 2]
Phase 2 trial update evaluating a higher dose of preoperative taMOxifen in premenopausal women with hormone receptor-positive breast cancer.
-
CLINICAL_TRIALS trial_result · 2024-04-23Clinical Trial Update: Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer [Phase 2]
A Phase II study of tetrathiomolybdate in breast cancer was terminated; results from the trial have been posted on ClinicalTrials.gov.
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel. [Phase 3]
Phase 3 trial evaluating trastuzumab plus pertuzumab (QL1209) with docetaxel in early-stage or locally advanced HER2-positive, ER/PR-negativ…
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer [Phase 2]
Phase 2 AVIATOR study evaluates trastuzumab and vinorelbine with either avelumab or utomilumab in advanced HER2-positive breast cancer; resu…
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating palbociclib and trastuzumab with endocrine therapy in HER2-positive metastatic breast cancer has completed enrollme…
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Chemotherapy Omission in ER+/HER2- Breast Cancer With 1-3 Positive Lymph Nodes Receiving Extended Adjuvant Abemaciclib [Phase 3]
Phase 3 trial investigating chemotherapy omission with extended adjuvant abemaciclib in ER+/HER2- breast cancer with 1-3 positive lymph node…